Cotinga Pharmaceuticals Company
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company’s lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene.COTQF Cotinga Pharmaceuticals Inc. - Seeking Alphaseekingalpha.com/symbol/COTQF
Headquarters:
Boston, Suffolk County, Massachusetts, United States
Employee Number:
11-50
Industry:
Clinical Development
Founded Date:
1999